Redeye makes minor revisions based on the Q2 report. We have changed the timing of some milestones to 2025e, but expect that they will receive the full amount by mid-2025e. The progress is evident in our view, even if it is still early in the commercialization process, and the recently announced milestone coming in Q3 is a good sign of progress. The outlook is still very promising. We nudge our fair value range upwards while increasing our Base case to SEK19.5 (18.7) per share